These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20795283)

  • 1. On call. My 64-year-old wife was recently diagnosed with osteoporosis. Her doctor said medication would help, and he reassured her that having osteoporosis was not all bad since it indicates a reduced risk for breast cancer. I want to know if osteoporosis in men affects the risk of prostate cancer.
    Simon HB
    Harv Mens Health Watch; 2010 Jul; 14(12):7-8. PubMed ID: 20795283
    [No Abstract]   [Full Text] [Related]  

  • 2. How do I know if my osteoporosis medication is working?
    Mayo Clin Womens Healthsource; 2009 Jan; 13(1):8. PubMed ID: 19043345
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Length of survival and causes of death in men with prostate cancer.
    Harv Mens Health Watch; 2010 Dec; 15(5):7. PubMed ID: 21207840
    [No Abstract]   [Full Text] [Related]  

  • 5. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
    Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
    Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate health: definitely a men's health issue.
    Porche DJ
    Am J Mens Health; 2008 Jun; 2(2):105. PubMed ID: 19477774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone and Men's Health. Male osteoporosis].
    Mori S
    Clin Calcium; 2010 Feb; 20(2):182-8. PubMed ID: 20118509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
    Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer in men: the importance of teaching and raising awareness.
    Al-Haddad M
    Clin J Oncol Nurs; 2010 Feb; 14(1):31-2. PubMed ID: 20118022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer treatment-induced bone loss.
    Adler RA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By the way, doctor. I'm 69 and have taking Fosamax for 10 years. My doctor has approved a "drug holiday," provided we use a CTX test to monitor my bones. Can you explain?
    Robb-Nicholson C
    Harv Womens Health Watch; 2009 May; 16(9):8. PubMed ID: 19554747
    [No Abstract]   [Full Text] [Related]  

  • 13. Early management of prostate cancer.
    Izard M
    Aust Fam Physician; 2010; 39(1-2):61-2. PubMed ID: 20369138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer].
    Izumi K; Mizokami A; Namiki M
    Clin Calcium; 2010 Feb; 20(2):175-81. PubMed ID: 20118508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trial.
    Nielsen D; Ryg J; Nissen N; Nielsen W; Knold B; Brixen K
    Scand J Public Health; 2008 Jun; 36(4):346-52. PubMed ID: 18539688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study.
    Weiss TW; Gold DT; Silverman SL; McHorney CA
    Curr Med Res Opin; 2006 May; 22(5):949-60. PubMed ID: 16709316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
    Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ
    Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women.
    Olevsky OM; Martino S
    Menopause; 2008; 15(4 Suppl):790-6. PubMed ID: 18596600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.